---
title: "301234.SZ (301234.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301234.SZ/news.md"
symbol: "301234.SZ"
name: "301234.SZ"
parent: "https://longbridge.com/en/quote/301234.SZ.md"
datetime: "2026-03-13T17:16:11.452Z"
locales:
  - [en](https://longbridge.com/en/quote/301234.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301234.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301234.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301234.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301234.SZ/news.md)


# 301234.SZ (301234.SZ) — Related News

### [WUZHOU MEDICAL: Zhou Lexiang and Pan Lanlan completed their share reduction](https://longbridge.com/en/news/269846599.md)
*2025-12-16T10:18:13.000Z*
> WUZHOU MEDICAL announced that shareholders Zhou Lexiang and Pan Lanlan have completed their reduction plan on December 1

### [WUZHOU MEDICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 18.5094 million yuan, a year-on-year decrease of 46.09%](https://longbridge.com/en/news/262379812.md)
*2025-10-23T08:39:03.000Z*
> According to the Zhitong Finance APP, WUZHOU MEDICAL released its third-quarter report for 2025. In the first three quar

### [Daily Investment and Financing Report in the Healthcare Sector (September 29): Yao has accelerated the completion of tens of millions of RMB in angel round financing](https://longbridge.com/en/news/259413546.md)
*2025-09-29T23:01:59.000Z*
> On September 29, 2025, a total of 3 investment and financing events were disclosed in the healthcare sector, involving 2

### [WUZHOU MEDICAL: Some shareholders plan to reduce their holdings by 1.86% of the company's shares](https://longbridge.com/en/news/259344343.md)
*2025-09-29T12:38:03.000Z*
> WUZHOU MEDICAL announced that some shareholders plan to reduce their holdings in the company, totaling a reduction of 1.

### [Yao Jiasu has secured angel round investment](https://longbridge.com/en/news/259261479.md)
*2025-09-29T06:06:59.000Z*
> On September 29, 2025, Hangzhou Yaojia Accelerated Medical Isotope Technology Co., Ltd. announced the completion of its 

### [WUZHOU MEDICAL: Shareholder Zhang Hongyu and his concerted actors' shareholding ratio decreased to 15%](https://longbridge.com/en/news/247300459.md)
*2025-07-04T11:25:10.000Z*
> WUZHOU MEDICAL announced that the concerted action agreement of the information disclosure obligor Zhang Hongyu has expi

### [WUZHOU MEDICAL: The "Joint Action Agreement" of the controlling shareholder and actual controller has expired and terminated, with Huang Fan becoming the new actual controller](https://longbridge.com/en/news/247298703.md)
*2025-07-04T11:17:50.000Z*
> WUZHOU MEDICAL announced that the "Consistent Action Agreement" signed by the company's controlling shareholders and act

### [WUZHOU MEDICAL: 49.572 million restricted shares will be listed and circulated starting from July 7](https://longbridge.com/en/news/246948507.md)
*2025-07-02T08:56:03.000Z*
> According to the Zhitong Finance APP, WUZHOU MEDICAL has issued a notice regarding the listing and circulation of shares

### [WUZHOU MEDICAL released its first-quarter performance, with a net profit attributable to the parent company of 5.6345 million yuan, a decrease of 43.00%](https://longbridge.com/en/news/237525560.md)
*2025-04-25T08:09:03.000Z*
> WUZHOU MEDICAL released its Q1 2025 performance, with operating revenue of 104 million yuan, a year-on-year increase of 

### [WUZHOU MEDICAL released its 2024 annual performance, with a net profit attributable to the parent company of 39.9698 million yuan, a decrease of 33.68%](https://longbridge.com/en/news/236593720.md)
*2025-04-18T13:40:03.000Z*
> WUZHOU MEDICAL released its 2024 annual report, with operating revenue of 477 million yuan, a year-on-year decrease of 1